★★★★★
Citicoline
★★★★★
Here is a new study( March 2022) showing the efficacy of Citicoline at just 250 mg/day for Glaucoma :
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907038/
Here is a relevant quote from the study :
>>> ' With oral citicoline treatment, the loss in the average RNFL is prevented in POAG patients in the short-term. Study data show that citicoline may have a significant impact on slowing glaucoma progression, which could have a potential neuroprotective effect.'<<<
In the following RCT (June 2020) it is shown that even eye drops utilizing Citicoline is effective for Glaucoma :
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337116/
Here is a relevant quote from the study :
>>> ' Additional treatment with citicoline eyedrops to IOP-lowering treatment might reduce disease progression in patients with progressing glaucoma despite IOP ≤18 mm Hg. ' <<<
In this last comprehensive review (March 2021) the protective role of Citicoline against the effects of glaucoma related neurodegeneration are elucidated in greater detail :
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003774/
Here is a relevant quote from the study :
>>> ' In addition to the evidences of an improvement of psychophysical, morphological, and electrophysiological outcomes, coming from small comparative randomized pilot clinical trials or larger not controlled before-after studies (performed in different ophthalmological neurodegenerative diseases, like OAG, AION, and DR), for the first time a reduction of the rate of visual field progression has been recently reported in OAG patients in a large randomized double-masked placebo-controlled clinical trial, thus further supporting the clinical use of citicoline. ' <<<
:::::::::::::::::::::::::::::::::::::
Art